ID20685A - Sediaan-sediaan farmasi silansetron yang distabilkan terhadap rasemisasi - Google Patents

Sediaan-sediaan farmasi silansetron yang distabilkan terhadap rasemisasi

Info

Publication number
ID20685A
ID20685A IDP981075A ID981075A ID20685A ID 20685 A ID20685 A ID 20685A ID P981075 A IDP981075 A ID P981075A ID 981075 A ID981075 A ID 981075A ID 20685 A ID20685 A ID 20685A
Authority
ID
Indonesia
Prior art keywords
silanetron
racemization
stabilized
pharmaceutical properties
pharmaceutical
Prior art date
Application number
IDP981075A
Other languages
English (en)
Indonesian (id)
Inventor
Ingo Bonnacker
Hartmut Kohn
Gerhard Kristen
Christine Reichel
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of ID20685A publication Critical patent/ID20685A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDP981075A 1997-08-01 1998-08-03 Sediaan-sediaan farmasi silansetron yang distabilkan terhadap rasemisasi ID20685A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19733271 1997-08-01
DE19813661A DE19813661A1 (de) 1997-08-01 1998-03-27 Gegen Racemisierung stabilisierte pharmazeutische Zubereitungen von Cilansetron

Publications (1)

Publication Number Publication Date
ID20685A true ID20685A (id) 1999-02-18

Family

ID=7837672

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP981075A ID20685A (id) 1997-08-01 1998-08-03 Sediaan-sediaan farmasi silansetron yang distabilkan terhadap rasemisasi

Country Status (29)

Country Link
US (1) US5977127A (ko)
EP (1) EP0895782B1 (ko)
JP (1) JP4324260B2 (ko)
KR (1) KR100515201B1 (ko)
CN (1) CN1117565C (ko)
AR (1) AR010178A1 (ko)
AT (1) ATE283706T1 (ko)
AU (1) AU743043B2 (ko)
BR (1) BR9803730A (ko)
CA (1) CA2244389C (ko)
CZ (1) CZ295072B6 (ko)
DE (2) DE19813661A1 (ko)
DK (1) DK0895782T3 (ko)
DZ (1) DZ2560A1 (ko)
ES (1) ES2234051T3 (ko)
HK (1) HK1017611A1 (ko)
HU (1) HUP9801712A3 (ko)
ID (1) ID20685A (ko)
IL (1) IL125403A (ko)
NO (1) NO323229B1 (ko)
NZ (1) NZ331083A (ko)
PL (1) PL191767B1 (ko)
PT (1) PT895782E (ko)
RU (1) RU2199318C2 (ko)
SK (1) SK284916B6 (ko)
TR (1) TR199801432A3 (ko)
TW (1) TW509570B (ko)
UA (1) UA62924C2 (ko)
ZA (1) ZA986715B (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7452545B2 (en) * 2001-11-13 2008-11-18 Yu Ruey J Oligosaccharide aldonic acids and their topical use
CA2439097C (en) * 2001-03-26 2010-10-12 Novartis Ag Pharmaceutical compositions
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
KR20050094843A (ko) * 2003-01-13 2005-09-28 다이노젠 파마세우티컬스, 인코포레이티드 욕지기, 구토, 구역질 또는 이들의 조합을 치료하는 방법
AU2004204825B2 (en) * 2003-01-13 2007-07-19 Dynogen Pharmaceuticals, Inc. Method of treating functional bowel disorders
ATE365554T1 (de) * 2003-04-04 2007-07-15 Dynogen Pharmaceuticals Inc Methode zur behandlung von erkrankungen der unteren harnwege
US7820690B2 (en) * 2004-03-19 2010-10-26 Solvay Pharmaceuticals Gmbh Method of treating or inhibiting a non-digestive tract derived abdominal disorder associated with pain using a 5-HT, receptor antagonist
US20060293309A1 (en) * 2005-03-28 2006-12-28 Dynogen Pharmaceuticals, Inc. Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors
JPWO2010018866A1 (ja) 2008-08-14 2012-01-26 杏林製薬株式会社 安定化された医薬組成物
EP4062973A4 (en) 2019-11-20 2023-11-29 Shionogi & Co., Ltd SOLID FORMULATION CONTAINING 6,7-UNSATURATED-7-CARBAMOYL MORPHINAND DERIVATIVE

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0297651B1 (en) * 1987-06-29 1993-11-03 Duphar International Research B.V Anellated indole derivatives
DE4238553A1 (de) * 1992-11-14 1994-05-19 Kali Chemie Pharma Gmbh Neue Imidazol-1-yl-Verbindungen enthaltende Arzneimittel
AU702594B2 (en) * 1995-10-13 1999-02-25 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds

Also Published As

Publication number Publication date
PL327786A1 (en) 1999-02-15
AU743043B2 (en) 2002-01-17
PT895782E (pt) 2005-02-28
CN1117565C (zh) 2003-08-13
DE19813661A1 (de) 1999-02-04
TR199801432A2 (xx) 1999-02-22
JPH1192369A (ja) 1999-04-06
ES2234051T3 (es) 2005-06-16
NO323229B1 (no) 2007-02-05
HUP9801712A3 (en) 2001-08-28
NZ331083A (en) 2000-01-28
HU9801712D0 (en) 1998-09-28
CZ236798A3 (cs) 1999-02-17
HUP9801712A2 (hu) 1999-04-28
NO983540L (no) 1999-02-02
CA2244389C (en) 2008-01-15
TW509570B (en) 2002-11-11
CN1207292A (zh) 1999-02-10
AU7863098A (en) 1999-02-11
DE59812317D1 (de) 2005-01-05
IL125403A (en) 2001-11-25
KR100515201B1 (ko) 2005-12-09
ZA986715B (en) 1999-02-04
ATE283706T1 (de) 2004-12-15
EP0895782B1 (de) 2004-12-01
NO983540D0 (no) 1998-07-31
DK0895782T3 (da) 2005-01-03
SK100998A3 (en) 1999-02-11
RU2199318C2 (ru) 2003-02-27
EP0895782A2 (de) 1999-02-10
SK284916B6 (sk) 2006-02-02
BR9803730A (pt) 2000-03-28
DZ2560A1 (fr) 2003-02-15
US5977127A (en) 1999-11-02
JP4324260B2 (ja) 2009-09-02
EP0895782A3 (de) 2001-01-31
IL125403A0 (en) 1999-03-12
AR010178A1 (es) 2000-05-17
CA2244389A1 (en) 1999-02-01
CZ295072B6 (cs) 2005-05-18
PL191767B1 (pl) 2006-06-30
TR199801432A3 (tr) 1999-02-22
KR19990023194A (ko) 1999-03-25
UA62924C2 (en) 2004-01-15
HK1017611A1 (en) 1999-11-26

Similar Documents

Publication Publication Date Title
ID26334A (id) Morfolinol yang aktif secara farmasi
ID23874A (id) Obat
ID24654A (id) Formulasi farmasi omeprazola
IS5953A (is) Lyfjablöndur úr örgerðum eplerenonum
ID22939A (id) Formulasi-formulasi farmasi yang mengandung vorikonozal
ID28110A (id) Surfaktan alkilbenzenasulfonat yang disempurnakan
NO20012915L (no) Ny farmasöytisk formulering
ID23299A (id) Formulasi-formulasi farmasi
ID29089A (id) Sediaan farmasi moksifloksasin
NO980546D0 (no) Farmasöytiske midler
DK1466615T3 (da) Farmaceutisk præparat
DK1017392T3 (da) Lægemiddel
DE69928344D1 (de) Pharmazeutisches Implantat
IS5331A (is) Ný lyfjablanda
ID20685A (id) Sediaan-sediaan farmasi silansetron yang distabilkan terhadap rasemisasi
ID16781A (id) Formulasi-formulasi farmasi
NO994619D0 (no) Farmasöytiske blandinger
FI973229A0 (fi) Uusi farmaseuttinen koostumus
DE69926012D1 (de) Arzneizubereitungen
NO20003141D0 (no) Farmasøytiske blandinger
ID18698A (id) Komposisi farmasi
EE9800275A (et) Misolastiini sisaldavad prolongeeritud toimega farmatseutilised preparaadid
FI973230A (fi) Uusi farmaseuttinen formulaatio
DE69906934D1 (de) Arzneizubereitungen
ITMI962628A0 (it) Composizione farmaceutica